Bullous erythema multiforme post Corbevax anti-COVID-19 vaccine: case report.

Downloads

DOI:

https://doi.org/10.26326/2281-9649.32.4.2403

How to Cite

Dave M., Mehta H., Nimbark D. 2022. Bullous erythema multiforme post Corbevax anti-COVID-19 vaccine: case report. Eur. J. Pediat. Dermatol. 32 (4):218-21. 10.26326/2281-9649.32.4.2403.

Authors

Dave M. Mehta H. Nimbark D.
pp. 218-21

Abstract

Vaccination against COVID-19 is key to reducing the impact of the disease. However, both COVID-19 and its vaccination can cause skin reactions. There are studies showing a link between erythema multiforme and COVID-19 infection; in some cases erythema multiforme can follow the anti-COVID-19 vaccination. The current report describes a case of bullous erythema multiforme that developed in a teenager after the Corbevax vaccine.

Keywords

vaccine, COVID 19, erythema multiforme

Issue

Vol. 32 No. 4 (2022)